Youkilis, a guy many people first heard about by virtue of him being prominently mentioned in “Moneyball” — and a guy who plays for arguably the most stat-savvy team in baseball — don’t need no stinkin’ sabermetrics:
“I don’t go off all those UZRs . . . is it UZR?” Youkilis said. “I
don’t even know what it is. I hope my UZR is sick, along with my OBSTR.
“I don’t know how they do it. How do you measure defense? You make
an error, you make an error. You get to a ball, you don’t get to a
ball. What if you have a bad hamstring and you can’t get to a ball up
the line? I don’t know what they evaluate, but a good ballplayer is a
And if I’m the Red Sox I’m perfectly happy with this answer. I want the players playing good defense — which Youkilis manifestly does — and not thinking too hard about how it rates. There are plenty of underpaid analysts on staff to worry about whether Youkilis’ UZR is sick.
Kristie Ackert of the New York Daily News reports that the Mets have discussed a trade involving starter Matt Harvey with at least two teams. Apparently, the Mets were even willing to move Harvey for a reliever.
The Mets tendered Harvey a contract on December 1. He’s entering his third and final year of arbitration eligibility and will likely see a slight bump from last season’s salary of $5.125 million. As a result, there was some thought going into late November that the Mets would non-tender Harvey.
Harvey, 28, made 18 starts and one relief appearance last year and had horrendous results. He put up a 6.70 ERA with a 67/47 K/BB ratio in 92 2/3 innings. Between his performance, his impending free agency, and his injury history, the Mets aren’t likely to get much back in return for Harvey. Even expecting a reliever in return may be too lofty.
Along with bullpen help, the Mets also need help at second base, first base, and the outfield. They don’t have many resources with which to address those needs. Ackert described the Mets’ resources as “a very limited stash of prospects” and “limited payroll space.”